The latest closing stock price for GT Biopharma as of September 18, 2024 is 2.18.
An investor who bought $1,000 worth of GT Biopharma stock at the IPO in 2021 would have $-579 today, roughly -1 times their original investment - a -19.46% compound annual growth rate over 4 years.
The all-time high GT Biopharma stock closing price was 18.96 on June 02, 2021.
The GT Biopharma 52-week high stock price is 10.66, which is 389% above the current share price.
The GT Biopharma 52-week low stock price is 0.17, which is 92.2% below the current share price.
The average GT Biopharma stock price for the last 52 weeks is 2.21.
An investor who bought $1,000 worth of GT Biopharma stock at the IPO in 2021 would have $-579 today, roughly -1 times their original investment - a -19.46% compound annual growth rate over 4 years.
The all-time high GT Biopharma stock closing price was 18.96 on June 02, 2021.
The GT Biopharma 52-week high stock price is 10.66, which is 389% above the current share price.
The GT Biopharma 52-week low stock price is 0.17, which is 92.2% below the current share price.
The average GT Biopharma stock price for the last 52 weeks is 2.21.